CN119630640A - 用于生产o-取代的丝氨酸衍生物的方法 - Google Patents

用于生产o-取代的丝氨酸衍生物的方法 Download PDF

Info

Publication number
CN119630640A
CN119630640A CN202380056648.8A CN202380056648A CN119630640A CN 119630640 A CN119630640 A CN 119630640A CN 202380056648 A CN202380056648 A CN 202380056648A CN 119630640 A CN119630640 A CN 119630640A
Authority
CN
China
Prior art keywords
optionally substituted
compound
acid
added
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380056648.8A
Other languages
English (en)
Chinese (zh)
Inventor
野木馨介
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN119630640A publication Critical patent/CN119630640A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202380056648.8A 2022-07-29 2023-07-28 用于生产o-取代的丝氨酸衍生物的方法 Pending CN119630640A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-121484 2022-07-29
JP2022121484 2022-07-29
PCT/JP2023/027836 WO2024024965A1 (ja) 2022-07-29 2023-07-28 Ｏ－置換セリン誘導体の製造方法

Publications (1)

Publication Number Publication Date
CN119630640A true CN119630640A (zh) 2025-03-14

Family

ID=89706696

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380056648.8A Pending CN119630640A (zh) 2022-07-29 2023-07-28 用于生产o-取代的丝氨酸衍生物的方法

Country Status (6)

Country Link
EP (1) EP4541787A1 (https=)
JP (1) JPWO2024024965A1 (https=)
KR (1) KR20250044666A (https=)
CN (1) CN119630640A (https=)
TW (1) TW202417460A (https=)
WO (1) WO2024024965A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4056580A4 (en) 2019-11-07 2023-12-06 Chugai Seiyaku Kabushiki Kaisha METHOD FOR PRODUCING A PEPTIDE COMPOUND COMPRISING A STERICALLY HINDERED AMINO ACID

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159747A (en) 1981-03-27 1982-10-01 Kenji Okawa Synthesis of amino acid derivative
WO2010053050A1 (ja) 2008-11-04 2010-05-14 株式会社カネカ Ｏ－アルキルセリンおよびｎ－ベンジル－ｏ－アルキルセリンの製造法
TW202446781A (zh) 2011-12-28 2024-12-01 日商中外製藥股份有限公司 胜肽化合物之製造方法
EP3878836B1 (en) 2018-11-07 2025-07-23 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
BR112022007535A2 (pt) * 2019-11-07 2022-07-12 Chugai Pharmaceutical Co Ltd Composto peptídico cíclico tendo ação inibitória de kras
EP4083051A4 (en) 2019-12-27 2024-01-17 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SYNTHESIS OF A PEPTIDE COMPOUND
WO2023023631A1 (en) * 2021-08-18 2023-02-23 Pardes Biosciences, Inc. Inhibitors of cysteine proteases and methods of use thereof

Also Published As

Publication number Publication date
WO2024024965A1 (ja) 2024-02-01
JPWO2024024965A1 (https=) 2024-02-01
KR20250044666A (ko) 2025-04-01
EP4541787A1 (en) 2025-04-23
TW202417460A (zh) 2024-05-01

Similar Documents

Publication Publication Date Title
US12312379B2 (en) Methods for producing cyclic compounds comprising N-substituted amino acid residues
JP7430297B2 (ja) Ｎ－アルキルアミノ酸、およびｎ－アルキルアミノ酸を含むペプチドの製造方法
EP4520748A1 (en) Method for producing salt of amino acid or salt of peptide compound or solvate of either one of said salts comprising lithium salt precipitation step
CN119630640A (zh) 用于生产o-取代的丝氨酸衍生物的方法
TW200524578A (en) Protease inhibitors
JP3254263B2 (ja) ホモキラルα−アミノアルデヒドのジアステレオ選択的な還元的ピナコールカップリング法
AP1221A (en) Process for preparing growth hormone secretagogues.
HK40117546A (zh) 用於生产o-取代的丝氨酸衍生物的方法
EP4596567A1 (en) Method for removing dibenzofulvene or dibenzofulvene derivative
Fu et al. Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potency
JP3254238B2 (ja) ホモキラルα−アミノアルデヒドのジアステレオ選択的な還元的ピナコールカップリング法
Vallette et al. Room temperature ionic liquids (RTIL’s) are convenient solvents for peptide synthesis!
WO2025192626A1 (ja) 環構造を有するペプチド化合物の製造方法
CN121941697A (zh) 用于使用两种或更多种添加剂生产肽化合物的方法
Cizio Total synthesis of beauvericin using dehydroamino acid residues to facilitate cyclization
AU2022269959A1 (en) Methods for producing cyclic compounds comprising N-substituted amino acid residues
HK40096738A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
WO2025143077A1 (ja) スタンドアローン型縮合剤を用いたペプチド化合物の製造方法
CN121532404A (zh) 用于使用混合酸酐程序生产肽化合物的方法
CN119156373A (zh) 包括锂盐沉淀步骤的用于生产氨基酸的盐或肽化合物的盐或所述盐中的任一者的溶剂化物的方法
US20260001882A1 (en) Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermediates thereof
EA049862B1 (ru) Способ получения циклического соединения, содержащего n-замещенный аминокислотный остаток
HK40120616A (zh) 用於生产含有n-取代氨基酸残基的环肽化合物的方法
CN118475590A (zh) N-烷基氨基酸以及包含n-烷基氨基酸的肽的制造方法
Raev Total Synthesis of Various Hormaomycin Analogues with Modified Amino Acid Residues

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40117546

Country of ref document: HK